 |
|
| Access educational resources for your patients to help them better understand and manage their CML. Learn more > |
| Since its development, Glivec® has been a cornerstone of therapy for CML patients. Learn more > |
Welcome to CMLAlliance.net |
Welcome to CMLAlliance.net, a CML resource from Novartis Oncology for healthcare professionals. Building on more than 5 years of worldwide experience in improving outcomes in Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML), Novartis Oncology introduces a new support program—CML Alliance. CML Alliance offers a wealth of resources designed to help you and your patients optimize outcomes in Ph+ CML. Access monitoring, educational, clinical trial information, and more. When patients have Ph+ CML, you want to provide access to the full potential of advanced care for Ph+ CML . . . and now you can with CML Alliance. |
